Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08VVZ
|
|||
| Former ID |
DNC000823
|
|||
| Drug Name |
J-104870
|
|||
| Synonyms |
145-13-1; 3-Hydroxypregn-5-en-20-one; 1-(3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl)ethanon; 1-(3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethanone; .DELTA.5-Pregnenolone; 5-Pregnene-3-ol-20-one; 5-Pregnen-3.beta.-ol-20-one; delta5-Pregnen-3beta-ol-20-one; Pregn-5-en-20-one, 3-hydroxy-; 3.beta.-Hydroxypregn-5-en-20-one; Pregn-5-en-20-one, 3.beta.-hydroxy-; AC1L1AKE; AC1Q1K1J; CHEMBL14116
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C27H33N5O4S2
|
|||
| Canonical SMILES |
CCC1=CN=C(S1)SCC2=NC(=CC(=C2)N3CCOCC3)NCC4=CC(=CC(=C4)OC)NC(=O)OCC=C
|
|||
| InChI |
1S/C27H33N5O4S2/c1-4-8-36-26(33)31-20-11-19(12-23(14-20)34-3)16-28-25-15-22(32-6-9-35-10-7-32)13-21(30-25)18-37-27-29-17-24(5-2)38-27/h4,11-15,17H,1,5-10,16,18H2,2-3H3,(H,28,30)(H,31,33)
|
|||
| InChIKey |
JNFARUXJNLDBCZ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
68389, 81295, 5056225, 8150933, 10521091, 24338999, 24439382, 26969646, 50952977, 51074657, 57320677, 85088893, 85174332, 85279114, 88216041, 103088357, 103149150, 104296555, 106189437, 117360646, 125325318, 125341159, 125863465, 126012463, 126012465, 126406984, 126440677, 126468321, 126688117, 128851440, 131011943, 134340141, 134340381, 135741211, 135983622, 137003857, 142422892, 162091262, 163112344, 165084771, 169674110, 179063987, 217594200, 235278644, 242084252, 251887445, 252402244
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Neuropeptide Y receptor type 1 (NPY1R) | Target Info | Antagonist | [1] |
| KEGG Pathway | cAMP signaling pathway | |||
| Neuroactive ligand-receptor interaction | ||||
| NetPath Pathway | FSH Signaling Pathway | |||
| Reactome | Peptide ligand-binding receptors | |||
| G alpha (i) signalling events | ||||
| WikiPathways | GPCRs, Class A Rhodopsin-like | |||
| Peptide GPCRs | ||||
| Endothelin Pathways | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The novel neuropeptide Y Y(1) receptor antagonist J-104870: a potent feeding suppressant with oral bioavailability. Biochem Biophys Res Commun. 1999 Dec 9;266(1):88-91. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.